Free Trial

Anavex Life Sciences (AVXL) Insider Trading & Ownership

Anavex Life Sciences logo
$8.97 +0.49 (+5.78%)
(As of 11:27 AM ET)

Anavex Life Sciences (NASDAQ:AVXL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.00%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$32,919.40
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$374,971.80
Get AVXL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Anavex Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AVXL Insider Buying and Selling by Quarter

Anavex Life Sciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2024Peter D.O. DonhauserDirectorBuy2,835$3.64$10,319.40  
5/15/2024Steffen ThomasDirectorBuy5,000$4.52$22,600.00  
3/28/2024Christopher U MisslingCEOSell73,380$5.11$374,971.80  
(Data available from 1/1/2013 forward)

AVXL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Anavex Life Sciences includes Athanasios Skarpelos, Christopher U Missling, Peter D.O. Donhauser, and Steffen Thomas. Learn more on insiders at AVXL.

11.00% of Anavex Life Sciences stock is owned by insiders. Learn more on AVXL's insider holdings.

The following insiders have purchased AVXL shares in the last 24 months: Peter D.O. Donhauser ($10,319.40), and Steffen Thomas ($22,600.00).

Insiders have purchased a total of 7,835 AVXL shares in the last 24 months for a total of $32,919.40 bought.

The following insider sold AVXL shares in the last 24 months: Christopher U Missling ($2,513,611.80).

Insiders have sold a total of 341,380 Anavex Life Sciences shares in the last 24 months for a total of $2,513,611.80 sold.

Anavex Life Sciences Key Executives

  • Dr. Christopher U. Missling M.B.A. (Age 58)
    M.S., Ph.D., President, CEO, Secretary & Director
    Compensation: $828.25k
  • Ms. Sandra Boenisch CPA (Age 43)
    CGA, Principal Financial Officer & Treasurer
    Compensation: $194.36k
  • Mr. Stephan Toutain M.B.A. (Age 58)
    M.S., Senior VP of Operations & COO
  • Dr. Walter E. Kaufmann M.D.
    Chief Scientific Officer
  • Clint Tomlinson
    VP of Corporate
  • Dr. Adebayo Laniyonu Ph.D.
    Senior Vice President of Nonclinical Development
  • Dr. Edward R Hammond M.D.
    M.P.H., Ph.D., Chief Medical Officer
  • Dr. Kun Jin Ph.D.
    Head of Biostatistics
  • Mr. David Goldberger R.Ph.
    Senior Vice President of Regulatory Affairs


This page (NASDAQ:AVXL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners